10/18/2018
Ryan Reed – Kansas Advance
Team: No. 16 Drive Down A1C Lilly Diabetes Ford Mustang
Crew Chief: Phil Gould
PR Contact: Nancy Padula; npadula@roushfenway.com; 704-743-3940
Twitter: @driverRyanReed, @Reed16Team and @RoushFenway
ADVANCE NOTES
Reed at Kansas
Ryan Reed will make his fifth NASCAR Xfinity Series start at Kansas Speedway this weekend. In his four previous starts at the 1.5-mile track, Reed’s best finish of 10th came in 2017.
Reed has an average finish of 13.8 at Kansas Speedway.
In two ARCA Racing Series starts at Kansas Speedway, Reed earned two top-10 finishes, crossing the finish line 10th in 2012 and fourth in 2015.
Kansas One Year Ago
Reed started the race 15th in his No. 16 Lilly Diabetes Ford Mustang and capitalized on chassis adjustments and fast pit stops throughout the race to earn a top-10 finish.
Reed on Kansas
“Kansas is one of those tracks where we have had really good runs. I’m going into this weekend looking to finish the season out strong.”
Ryan Reed and Lilly Diabetes are encouraging and motivating NASCAR fans to better manage their diabetes by visiting www.DriveDownA1C.com to learn more about resources and treatment options.
Did You Know?
Ryan Reed was diagnosed at the age of 17 with Type 1 Diabetes. Through hard work, perseverance and working with his doctors he’s been able to manage his diabetes and set an example to others.
About Lilly Diabetes
Lilly has been a global leader in diabetes care since 1923, when we introduced the world’s first commercial insulin. Today we are building upon this heritage by working to meet the diverse needs of people with diabetes and those who care for them. Through research, collaboration and quality manufacturing we strive to make life better for people affected by diabetes. We offer a wide range of therapies and a continued determination to provide real solutions—from medicines and technologies to support programs and more. For the latest updates, visit https://www.lillydiabetes.com/ or follow us on Twitter: @LillyDiabetes and Facebook: LillyDiabetesUS.